RUBRA MEDICAMENTS LTD. - 531099 - Unaudited Financial Result For The Quarter Ended September 30, 2019 Alongwith Limited Review Report
Unaudited Financial Result For The Quarter Ended September 30, 2019 Alongwith Limited Review Report14-11-2019
RUBRA MEDICAMENTS LTD. - 531099 - Unaudited Financial Result For The Quarter Ended September 30, 2019 Alongwith Limited Review Report
Unaudited Financial Result For The Quarter Ended September 30, 2019 Alongwith Limited Review ReportRUBRA MEDICAMENTS LTD. - 531099 - Board Meeting Intimation for Unaudited Standalone Financial Results Of The Company For The Quarter Ended September 30, 2019 Along With Limited Review Report Thereon
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Unaudited Standalone Financial Results of the Company for the Quarter ended September 30, 2019 along with Limited Review Report thereonRUBRA MEDICAMENTS LTD. - 531099 - Compliance Certificate For The Half Year Ended September 30, 2019
Compliance certificate for the half year ended September 30, 2019Rubra Medicaments Ltd - 531099 - Shareholding for the Period Ended September 30, 2019
Rubra Medicaments Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click hereRUBRA MEDICAMENTS LTD. - 531099 - Compliance Certificate For The Half Year Ended September 30, 2019
Compliance Certificate For The Half Year Ended September 30, 2019RUBRA MEDICAMENTS LTD. - 531099 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abha KapoorDesignation :- DirectorRUBRA MEDICAMENTS LTD. - 531099 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Rubra Medicaments Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click hereRUBRA MEDICAMENTS LTD. - 531099 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of AGM dated September 30, 2019Rubra Medicaments Ltd - 531099 - Notice Of 28Th Annual General Meeting Of The Company
Notice of 28th Annual General Meeting of the CompanyRUBRA MEDICAMENTS LTD. - 531099 - Reg. 34 (1) Annual Report
Annual Report of the Company for the FY 2018-19